170 related articles for article (PubMed ID: 22899581)
1. Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients.
Labrador J; Lopez-Anglada L; Perez-Lopez E; Lozano FS; Lopez-Corral L; Sanchez-Guijo FM; Vazquez L; Perez Rivera JA; Martin-Herrero F; Sanchez-Barba M; Guerrero C; del Cañizo MC; Caballero MD; San Miguel JF; Alberca I; Gonzalez-Porras JR
Haematologica; 2013 Mar; 98(3):437-43. PubMed ID: 22899581
[TBL] [Abstract][Full Text] [Related]
2. Incidence and risk factors for life-threatening bleeding after allogeneic stem cell transplant.
Labrador J; López-Corral L; Vazquez L; Sánchez-Guijo F; Guerrero C; Sánchez-Barba M; Lozano FS; Alberca I; Del Cañizo MC; Caballero D; González-Porras JR
Br J Haematol; 2015 Jun; 169(5):719-25. PubMed ID: 25817436
[TBL] [Abstract][Full Text] [Related]
3. Venous thromboembolism is associated with graft-
Kekre N; Kim HT; Ho VT; Cutler C; Armand P; Nikiforow S; Alyea EP; Soiffer RJ; Antin JH; Connors JM; Koreth J
Haematologica; 2017 Jul; 102(7):1185-1191. PubMed ID: 28341735
[TBL] [Abstract][Full Text] [Related]
4. Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics.
Keklik F; Alrawi EB; Cao Q; Bejanyan N; Rashidi A; Lazaryan A; Arndt P; Dincer EH; Bachanova V; Warlick ED; MacMillan ML; Arora M; Miller J; Brunstein CG; Weisdorf DJ; Ustun C
Haematologica; 2018 Dec; 103(12):2109-2115. PubMed ID: 30076172
[TBL] [Abstract][Full Text] [Related]
5. Thrombotic and hemorrhagic complications in children and young adult recipients of Hematopoietic Stem Cell Transplant (HSCT).
Kaur D; Ashrani AA; Pruthi R; Khan SP; Bailey K; Rodriguez V
Thromb Res; 2018 Jul; 167():44-49. PubMed ID: 29787942
[TBL] [Abstract][Full Text] [Related]
6. Transplant-associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation.
Gavriilaki E; Sakellari I; Batsis I; Mallouri D; Bousiou Z; Vardi A; Yannaki E; Constantinou V; Tsompanakou A; Vadikoliou C; Kaloyannidis P; Bamihas G; Anagnostopoulos A
Clin Transplant; 2018 Sep; 32(9):e13371. PubMed ID: 30080283
[TBL] [Abstract][Full Text] [Related]
7. Dynamic International Prognostic Scoring System scores, pre-transplant therapy and chronic graft-versus-host disease determine outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis.
Ditschkowski M; Elmaagacli AH; Trenschel R; Gromke T; Steckel NK; Koldehoff M; Beelen DW
Haematologica; 2012 Oct; 97(10):1574-81. PubMed ID: 22491742
[TBL] [Abstract][Full Text] [Related]
8. Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia.
Ram R; Storb R; Sandmaier BM; Maloney DG; Woolfrey A; Flowers ME; Maris MB; Laport GG; Chauncey TR; Lange T; Langston AA; Storer B; Georges GE
Haematologica; 2011 Aug; 96(8):1113-20. PubMed ID: 21508120
[TBL] [Abstract][Full Text] [Related]
9. Clinical Outcomes of Fludarabine and Melphalan With an 800 cGy Total Body Irradiation Conditioning Regimen in Patients With Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
Jeon YW; Yoon S; Min GJ; Park SS; Park S; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Lee JW; Cho SG
Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):345-355.e7. PubMed ID: 31014757
[TBL] [Abstract][Full Text] [Related]
10. Risk and prognostic factors of transplantation-associated thrombotic microangiopathy in allogeneic haematopoietic stem cell transplantation: a nested case control study.
Ye Y; Zheng W; Wang J; Hu Y; Luo Y; Tan Y; Shi J; Zhang M; Huang H
Hematol Oncol; 2017 Dec; 35(4):821-827. PubMed ID: 27245857
[TBL] [Abstract][Full Text] [Related]
11. HLA-DQB1 mismatch increase risk of severe bleeding independently in recipients of allogeneic stem cell transplant.
Qi J; Zhang R; Cai C; Wang H; Zhou M; Shen W; Tang Y; Pan T; Wu D; Han Y
Ann Hematol; 2021 Sep; 100(9):2351-2361. PubMed ID: 33846855
[TBL] [Abstract][Full Text] [Related]
12. Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival.
Lunde LE; Dasaraju S; Cao Q; Cohn CS; Reding M; Bejanyan N; Trottier B; Rogosheske J; Brunstein C; Warlick E; Young JA; Weisdorf DJ; Ustun C
Bone Marrow Transplant; 2015 Nov; 50(11):1432-7. PubMed ID: 26168069
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors for Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation with Umbilical Cord Blood and Matched Sibling Donors.
Lazaryan A; Weisdorf DJ; DeFor T; Brunstein CG; MacMillan ML; Bejanyan N; Holtan S; Blazar BR; Wagner JE; Arora M
Biol Blood Marrow Transplant; 2016 Jan; 22(1):134-40. PubMed ID: 26365153
[TBL] [Abstract][Full Text] [Related]
14. Neurologic complications after allogeneic hematopoietic stem cell transplantation in children: analysis of prognostic factors.
Kang JM; Kim YJ; Kim JY; Cho EJ; Lee JH; Lee MH; Lee SH; Sung KW; Koo HH; Yoo KH
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1091-8. PubMed ID: 25708217
[TBL] [Abstract][Full Text] [Related]
15. Ex Vivo CD34
Barba P; Hilden P; Devlin SM; Maloy M; Dierov D; Nieves J; Garrett MD; Sogani J; Cho C; Barker JN; Kernan NA; Castro-Malaspina H; Jakubowski AA; Koehne G; Papadopoulos EB; Prockop S; Sauter C; Tamari R; van den Brink MR; Avecilla ST; Meagher R; O'Reilly RJ; Goldberg JD; Young JW; Giralt S; Perales MA; Ponce DM
Biol Blood Marrow Transplant; 2017 Mar; 23(3):452-458. PubMed ID: 28017734
[TBL] [Abstract][Full Text] [Related]
16. Epileptic seizures in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors, and survival rates.
Zhang XH; Xu LP; Liu DH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Wang Y; Zhao T; Chen Y; Fu HX; Liu KY; Huang XJ
Clin Transplant; 2013; 27(1):80-9. PubMed ID: 22938074
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
[TBL] [Abstract][Full Text] [Related]
18. Risk of graft-versus-host disease with rituximab-containing conditioning regimens in allogeneic hematopoietic stem cell transplant.
Marini BL; Markstrom D; Frame D
J Oncol Pharm Pract; 2017 Jun; 23(4):255-263. PubMed ID: 26970572
[TBL] [Abstract][Full Text] [Related]
19. Association Between Low Plasma Level of Citrulline Before Allogeneic Hematopoietic Cell Transplantation and Severe Gastrointestinal Graft vs Host Disease.
Hueso T; Gauthier J; Joncquel Chevalier-Curt M; Magro L; Coiteux V; Dulery R; Carpentier B; Labreuche J; Damaj G; Yakoub-Agha I; Seguy D
Clin Gastroenterol Hepatol; 2018 Jun; 16(6):908-917.e2. PubMed ID: 29258901
[TBL] [Abstract][Full Text] [Related]
20. Thrombotic microangiopathy with concomitant GI aGVHD after allogeneic hematopoietic stem cell transplantation: Risk factors and outcome.
Zhang XH; Liu X; Wang QM; He Y; Zhu XL; Zhang JM; Han W; Chen H; Chen YH; Wang FR; Wang JZ; Zhang YY; Mo XD; Chen Y; Wang Y; Fu HX; Chang YJ; Xu LP; Liu KY; Huang XJ
Eur J Haematol; 2018 Feb; 100(2):171-181. PubMed ID: 29114931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
